12178 Federal Register / Vol. 72, No.
50 / Thursday, March 15, 2007 / Notices
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of scientific merit of grant
applications received in response to RFA
DD07–006, ‘‘China-United States
Collaborative, Population-Based Surveillance
and Research Program for Maternal-Child
and Family Health.’’
For Further Information Contact: Juliana
Cyril, Ph.D., Scientific Review Administrator,
Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop D72, Atlanta,
GA 30333, Telephone 404.639.4639.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 8, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–4744 Filed 3–14–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Childhood
Agriculture Safety and Health
Research, Request for Applications
(RFA) OH 07–002
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–3 p.m., April
16, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
No. of
21 CFR Section
Recordkeepers
589.2000(e)(1)(iv)
rmajette on PROD1PC67 with NOTICES
1There are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Aug<31>2005 14:20 Mar 14, 2007 Jkt 211001
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of applications received in
response to RFA OH 07–002,
‘‘Childhood Agriculture Safety and
Health Research.’’
Contact Person For More Information:
Stephen Olenchock, Scientific Review
Administrator, Office of Extramural
Coordination and Special Projects,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Mailstop P–04,
Morgantown, WV 26506, Telephone
304–285–6271.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–4745 Filed 3–14–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0472]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Substances
Prohibited From Use in Animal Food or
Feed; Animal Proteins Prohibited in
Ruminant Feed
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
Annual Frequency
per Recordkeeping
400 1 400
PO 00000 Frm 00015 Fmt 4703 Sfmt 4703
DATES: Fax written comments on the
collection of information by April 16,
2007.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301– 827–
1472.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Substances Prohibited from Use in
Animal Food or Feed; Animal Proteins
Prohibited in Ruminant Feed—21 CFR
589.2000(e)(1)(iv) (OMB Control
Number 0910–0339)—Extension
This information collection was
established because epidemiological
evidence gathered in the United
Kingdom suggested that bovine
spongiform encephalopathy (BSE), a
progressively degenerative central
nervous system disease, is spread to
ruminant animals by feeding protein
derived from ruminants infected with
BSE. That regulation places general
requirements on persons that
manufacture, blend, process, and
distribute products that contain or may
contain protein derived from
mammalian tissue, and feeds made from
such products.
In the Federal Register of December 4,
2006 (71 FR 70409), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received.
The respondents for this collection of
information are manufacturers and or
distributors of products that contain or
may contain protein derived from
mammalian tissues and feeds made
from such products.
Total Annual Hours per
Total Hours
Records Record
14 5,600
E:\FR\FM\15MRN1.SGM 15MRN1